AMLX Amylyx Pharmaceuticals, Inc.

NASDAQ
$27.62

Amylyx Pharmaceuticals, Inc. (AMLX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with AMLX's own trailing one-year pace, with 32% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 6 sellers in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
6
13 transactions
Purchases
$51.3K
3,800 shares
Sales
$4.3M
151,302 shares
Net activity
-$4.3M
purchases less sales

How much of that selling was preplanned? 32% planned / 68% discretionary

10b5-1 plan sales $1.4M 3 transactions · 60,000 shares
Discretionary sales $2.9M 10 transactions · 91,302 shares

Largest single sale: $950.0K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: May 21, 2026 , by Firestone Karen .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
MILNE GEORGE M JR Director Sell 10b5-1 30,000 $27.70 $830.9K 782,881 −3.7% of holding
Cohen Joshua B 2 fills Co-Chief Executive Officer Sell 30,464 $32.19 $980.5K 3,614,042 −0.8% of holding
Klee Justin B. 2 fills Co-Chief Executive Officer Sell 30,464 $32.18 $980.3K 3,614,495 −0.8% of holding
FRATES JAMES M 2 fills Chief Financial Officer Sell 10,810 $32.36 $349.8K 234,667 −4.4% of holding
Bedrosian Camille L 2 fills Chief Medical Officer Sell 10,028 $32.40 $324.9K 280,145 −3.5% of holding
Mazzariello Gina 2 fills Chief Legal Officer Sell 9,536 $32.46 $309.5K 190,849 −4.8% of holding
Mazzariello Gina Chief Legal Officer Sell 10b5-1 15,000 $17.61 $264.1K 179,090 −7.7% of holding
Mazzariello Gina Chief Legal Officer Sell 10b5-1 15,000 $18.32 $274.7K 194,090 −7.2% of holding
Firestone Karen Director Buy 3,800 $13.51 $51.3K 66,900

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.